Chu LL - Search Results

1

In vivo validation of PAX2 as a target for renal cancer therapy.

Hueber PA, Iglesias D, Chu LL, Eccles M, Goodyer P. Hueber PA, et al. Among authors: chu ll. Cancer Lett. 2008 Jun 28;265(1):148-55. doi: 10.1016/j.canlet.2008.02.016. Epub 2008 Apr 24. Cancer Lett. 2008. PMID: 18439754

2

WT1 is a modifier of the Pax2 mutant phenotype: cooperation and interaction between WT1 and Pax2.

Discenza MT, He S, Lee TH, Chu LL, Bolon B, Goodyer P, Eccles M, Pelletier J. Discenza MT, et al. Among authors: chu ll. Oncogene. 2003 Nov 6;22(50):8145-55. doi: 10.1038/sj.onc.1206997. Oncogene. 2003. PMID: 14603255

3

PAX2 activates WNT4 expression during mammalian kidney development.

Torban E, Dziarmaga A, Iglesias D, Chu LL, Vassilieva T, Little M, Eccles M, Discenza M, Pelletier J, Goodyer P. Torban E, et al. Among authors: chu ll. J Biol Chem. 2006 May 5;281(18):12705-12. doi: 10.1074/jbc.M513181200. Epub 2005 Dec 19. J Biol Chem. 2006. PMID: 16368682 Free article.

4

Canonical WNT signaling during kidney development.

Iglesias DM, Hueber PA, Chu L, Campbell R, Patenaude AM, Dziarmaga AJ, Quinlan J, Mohamed O, Dufort D, Goodyer PR. Iglesias DM, et al. Am J Physiol Renal Physiol. 2007 Aug;293(2):F494-500. doi: 10.1152/ajprenal.00416.2006. Epub 2007 May 9. Am J Physiol Renal Physiol. 2007. PMID: 17494089 Free article.

5

PAX3 is expressed in the stromal compartment of the developing kidney and in Wilms tumors with myogenic phenotype.

Hueber PA, Fukuzawa R, Elkares R, Chu L, Blumentkrantz M, He SJ, Anaka MR, Reeve AE, Eccles M, Jabado N, Iglesias DM, Goodyer PR. Hueber PA, et al. Pediatr Dev Pathol. 2009 Sep-Oct;12(5):347-54. doi: 10.2350/08-05-0466.1. Pediatr Dev Pathol. 2009. PMID: 18666806

6

Targeted inactivation of EGF receptor inhibits renal collecting duct development and function.

Zhang Z, Pascuet E, Hueber PA, Chu L, Bichet DG, Lee TC, Threadgill DW, Goodyer P. Zhang Z, et al. J Am Soc Nephrol. 2010 Apr;21(4):573-8. doi: 10.1681/ASN.2009070719. Epub 2010 Feb 4. J Am Soc Nephrol. 2010. PMID: 20133479 Free PMC article.

7

T-cell factor/β-catenin activity is suppressed in two different models of autosomal dominant polycystic kidney disease.

Miller MM, Iglesias DM, Zhang Z, Corsini R, Chu L, Murawski I, Gupta I, Somlo S, Germino GG, Goodyer PR. Miller MM, et al. Kidney Int. 2011 Jul;80(2):146-53. doi: 10.1038/ki.2011.56. Epub 2011 Mar 9. Kidney Int. 2011. PMID: 21389971 Free PMC article.

8

A variant OSR1 allele which disturbs OSR1 mRNA expression in renal progenitor cells is associated with reduction of newborn kidney size and function.

Zhang Z, Iglesias D, Eliopoulos N, El Kares R, Chu L, Romagnani P, Goodyer P. Zhang Z, et al. Hum Mol Genet. 2011 Nov 1;20(21):4167-74. doi: 10.1093/hmg/ddr341. Epub 2011 Aug 5. Hum Mol Genet. 2011. PMID: 21821672

9

Stem cell microvesicles transfer cystinosin to human cystinotic cells and reduce cystine accumulation in vitro.

Iglesias DM, El-Kares R, Taranta A, Bellomo F, Emma F, Besouw M, Levtchenko E, Toelen J, van den Heuvel L, Chu L, Zhao J, Young YK, Eliopoulos N, Goodyer P. Iglesias DM, et al. PLoS One. 2012;7(8):e42840. doi: 10.1371/journal.pone.0042840. Epub 2012 Aug 13. PLoS One. 2012. PMID: 22912749 Free PMC article.

10

Wilms tumor suppressor, WT1, suppresses epigenetic silencing of the β-catenin gene.

Akpa MM, Iglesias DM, Chu LL, Cybulsky M, Bravi C, Goodyer PR. Akpa MM, et al. Among authors: chu ll. J Biol Chem. 2015 Jan 23;290(4):2279-88. doi: 10.1074/jbc.M114.573576. Epub 2014 Oct 20. J Biol Chem. 2015. PMID: 25331950 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

108 results

Search Page